Optometrists in Seabrook, NH Accepting Medicare
5 Optometrists found. Showing 1 - 5
 Dr. Matthew D. Foley & Associates, Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 270 Lafayette Rd, Suite 13, Seabrook, NH 03874 Phone: 603-474-3781 |
 Dr. Chang Soo Daniel Lee, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 700 Lafayette Rd, Unit 1, Seabrook, NH 03874 Phone: 603-474-1681 Fax: 603-474-0695 |
Derrick Y. Chung, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 779 Lafayette Rd. Unit 5, Seabrook, NH 03874 Phone: 603-474-3781 Fax: 603-574-4839 |
Elite Eye Center Optometrist Medicare: Medicare Enrolled Practice Location: 779 Lafayette Rd. Unit 5, Seabrook, NH 03874 Phone: 603-474-3781 Fax: 603-574-4839 |
Visionworks Optometrist Medicare: Not Enrolled in Medicare Practice Location: 652 Lafayette Rd, Unit 3, Seabrook, NH 03874 Phone: 603-474-0297 Fax: 603-474-0269 |
News Archive
Nanocontainers show drug delivery potential
Tiny chemical cages created by researchers at Rutgers, The State University of New Jersey, show potential for delivering drugs to organs or tissues where they're needed without causing harm elsewhere.
Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer
The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis' therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.
Scientists identify RIOK1 enzyme as new target for cancer therapy
Dr. Florian Weinberg, from Prof. Dr. Tilman Brummer's research group at the Institute of Molecular Medicine and Cell Research of the University of Freiburg, joined forces with scientists from the Departments of Clinical Pathology and Medicine I of the University Medical Centre Freiburg and the Kinghorn Cancer Centre/Garvan Insitute in Australia in an international team that has identified a new target for cancer therapy.
Researchers use ultrasound to improve quality of blood stem cell transplant
Transplantation of haematopoietic stem cells is an effective treatment for patients with malignant blood diseases. The composition and quality of the transplanted cells are crucial to the outcome. Researchers from Lund University, Sweden, have now developed a method to improve the quality of the transplanted cells using ultrasound for cell separation.
› Verified 4 days ago
Physical Therapists
Chiropractors
Optometrists
Occupational Therapists